{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:27:37Z","timestamp":1787758057047,"version":"build-2784847793"},"reference-count":85,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:p>Lactoferrin (LF) is an iron-binding glycoprotein released from mucous secreting cells and neutrophils. LF can be used in a broad range of eye diseases related to the retina, cornea, and optic nerve. The retina is particularly affected by oxidative stress inside the photoreceptor being constantly exposed to light which induces accumulation of reactive oxygen species (ROS) in the retinal pigmented epithelium (RPE) causing damage to photoreceptor recycling. Retinitis pigmentosa (RP) and macular degeneration are inherited retinopathies that consist of different disease-causing genes, that cause mutations with highly varied clinical consequences. Age-related macular degeneration is a chronic disease of the retina and one of the major causes of sight loss. This review provides an application of lactoferrin and LF-based nano-formulations or nanoparticles in the field of retinal diseases or corneal diseases such as retinitis pigmentosa, retinoblastoma, age-related macular degeneration (AMD), keratoconus and uveitis. Several studies have found that lactoferrin\u2019s antibacterial activity is not limited to its iron sequestration, but also its ability as a nanoparticle that acts as a carrier to deliver drugs by crossing the blood\u2013retina barrier (BRB) and its involvement in cell cycle control, which is not possible by many transferrin proteins.<\/jats:p>","DOI":"10.4103\/ijo.ijo_303_22","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T06:28:32Z","timestamp":1657607312000},"page":"2328-2334","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Lactoferrin and its nano-formulations in rare eye diseases"],"prefix":"10.4103","volume":"70","author":[{"given":"Jiya","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohita","family":"Sharma","sequence":"additional","affiliation":[{"name":"Tirupati Eye Centre and Research Institute, Noida, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Jain","sequence":"additional","affiliation":[{"name":"The Cornea Institute, KAR Campus, L V Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insha","family":"Aftab","sequence":"additional","affiliation":[{"name":"Tirupati Eye Centre and Research Institute, Noida, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naval","family":"Vikram","sequence":"additional","affiliation":[{"name":"Department of Medicine, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tej P","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"key":"B1-20240828","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1442-9071.2010.02363.x","article-title":"Anatomy and physiology of the human eye:effects of mucopolysaccharidoses disease on structure and function\u2013a review","volume":"38","author":"Willoughby","year":"2010","journal-title":"Clinical &Experimental Ophthalmology."},{"key":"B2-20240828","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s13205-017-0878-3","article-title":"Genetic characterization and disease mechanism of retinitis pigmentosa;current scenario","volume":"7","author":"Ali","year":"2017","journal-title":"3 Biotech"},{"key":"B3-20240828","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-1-31","article-title":"Retinoblastoma","volume":"1","author":"Aerts","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"B4-20240828","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/13816810.2020.1747090","article-title":"Atypical and ultra-rare Usher syndrome:A review","volume":"41","author":"Nolen","year":"2020","journal-title":"Ophthalmic Genet"},{"key":"B6-20240828","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ajhg.2010.04.001","article-title":"A splice-site mutation in a retina-specific exon of BBS8 causes nonsyndromic retinitis pigmentosa","volume":"86","author":"Riazuddin","year":"2010","journal-title":"Am J Hum Genet"},{"key":"B7-20240828","doi-asserted-by":"crossref","first-page":"15021","DOI":"10.1038\/nrdp.2015.21","article-title":"Retinoblastoma","volume":"1","author":"Dimaras","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"B8-20240828","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/hmg\/ddn024","article-title":"Loss of RB1 induces non-proliferative retinoma:Increasing genomic instability correlates with progression to retinoblastoma","volume":"17","author":"Dimaras","year":"2008","journal-title":"Hum Mol Genet"},{"key":"B10-20240828","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1136\/bjo.2008.150292","article-title":"The epidemiological challenge of the most frequent eye cancer:Retinoblastoma, an issue of birth and death","volume":"93","author":"Kivel\u00e4","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"B12-20240828","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/bjo.2008.138750","article-title":"Incidence of retinoblastoma in the USA 1975-2004","volume":"93","author":"Broaddus","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"B13-20240828","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0140-6736(11)61137-9","article-title":"Retinoblastoma","volume":"379","author":"Dimaras","year":"2012","journal-title":"Lancet"},{"key":"B14-20240828","doi-asserted-by":"crossref","first-page":"301-e1","DOI":"10.1016\/j.ijantimicag.2008.07.020","article-title":"Lactoferrin:Structure, function and applications","volume":"33","author":"Gonz\u00e1lez-Ch\u00e1vez","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"B15-20240828","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000489093","article-title":"Age-related dry eye lactoferrin and lactobionic acid","volume":"60","author":"Rusciano","year":"2018","journal-title":"Ophthalmic Res"},{"key":"B16-20240828","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1271\/bbb.56.2079","article-title":"Antioxidant activity of bovine lactoferrin on iron\/ascorbate induced lipid peroxidation","volume":"12","author":"Shinmoto","year":"1992","journal-title":"Biosci Biotech Biochem"},{"key":"B17-20240828","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1755-3768.1994.tb02791.x","article-title":"Ocular surface damage and tear lactoferrin in dry eye syndrome","volume":"72","author":"Danjo","year":"1994","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"B18-20240828","first-page":"NC06","article-title":"Effect of oral lactoferrin on cataract surgery induced dry eye:A randomised controlled trial","volume":"9","author":"Devendra","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"B19-20240828","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/jop.1998.14.99","article-title":"Lactoferrin suppresses loss of corneal epithelial integrity in a rabbit short-term dry eye model","volume":"14","author":"Fujihara","year":"1998","journal-title":"J Ocul Pharmacol Ther"},{"key":"B20-20240828","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0304-4165(68)90015-9","article-title":"Inhibition of bacteria by lactoferrin and other iron-chelating agents","volume":"170","author":"Oram","year":"1968","journal-title":"Biochim Biophys Acta"},{"key":"B21-20240828","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1007\/s00216-013-6943-9","article-title":"A high-throughput method for the quantification of iron saturation in lactoferrin preparations","volume":"405","author":"Majka","year":"2013","journal-title":"Anal Bioanal Chem"},{"key":"B22-20240828","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3389\/fimmu.2017.01438","article-title":"Lactoferrin in a context of inflammation-induced pathology","volume":"8","author":"Kruzel","year":"2017","journal-title":"Front Immunol"},{"key":"B23-20240828","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000315016","article-title":"Antimicrobial peptides as a major part of the innate immune defense at the ocular surface","volume":"45","author":"Garreis","year":"2010","journal-title":"Dev Ophthalmol"},{"key":"B24-20240828","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000489093","article-title":"Age-related dry eye lactoferrin and lactobionic acid","volume":"60","author":"Rusciano","year":"2018","journal-title":"Ophthalmic Res"},{"key":"B25-20240828","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1167\/iovs.61.12.9","article-title":"Lactoferrin concentration in human tears and ocular diseases:A meta-analysis","volume":"61","author":"Ponzini","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B26-20240828","first-page":"H1149","article-title":"Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells","volume":"270","author":"Descamps","year":"1996","journal-title":"Am J Physiol"},{"key":"B27-20240828","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1074\/jbc.274.11.7011","article-title":"Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier","volume":"274","author":"Fillebeen","year":"1999","journal-title":"J Biol Chem"},{"key":"B28-20240828","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1096\/fj.09-139147","article-title":"Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in an improved phenotype in a mouse model of retinitis pigmentosa","volume":"24","author":"Cai","year":"2010","journal-title":"FASEB J"},{"key":"B29-20240828","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ijbiomac.2014.07.041","article-title":"Carboplatin loaded protein nanoparticles exhibit improve anti-proliferative activity in retinoblastoma cells","volume":"70","author":"Ahmed","year":"2014","journal-title":"Int J Biol Macromol"},{"key":"B30-20240828","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1167\/iovs.02-1104","article-title":"Cone and rod ERG phototransduction parameters in retinitis pigmentosa","volume":"44","author":"Tzekov","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B31-20240828","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","article-title":"Retinitis pigmentosa","volume":"368","author":"Hartong","year":"2006","journal-title":"Lancet"},{"key":"B32-20240828","first-page":"3742","article-title":"Non-syndromic retinitis pigmentosa due to mutations in the mucopolysaccharidosis type IIIC gene, heparan-alpha-glucosaminide N-acetyltransferase (HGSNAT)","volume":"24","author":"Haer-Wigman","year":"2015","journal-title":"Hum Mol Genet"},{"key":"B33-20240828","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.ophtha.2010.10.047","article-title":"CLRN1 mutations cause nonsyndromic retinitis pigmentosa","volume":"118","author":"Khan","year":"2011","journal-title":"Ophthalmology"},{"key":"B34-20240828","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0888-7543(90)90284-2","article-title":"Multipoint linkage analysis and heterogeneity testing in 20 X-linked retinitis pigmentosa families","volume":"8","author":"Musarella","year":"1990","journal-title":"Genomics"},{"key":"B35-20240828","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1167\/iovs.04-0020","article-title":"Severe retinal degeneration associated with disruption of semaphorin 4A","volume":"45","author":"Rice","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B36-20240828","first-page":"305","article-title":"Inhibition of hydroxyl radical formation by human tears Invest","volume":"28","author":"Kuizenga","year":"1987","journal-title":"Ophthalmol Vis Sci"},{"key":"B37-20240828","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/eye.2016.197","article-title":"A challenge to the striking genotypic heterogeneity of retinitis pigmentosa:A better understanding of the pathophysiology using the newest genetic strategies","volume":"30","author":"Sorrentino","year":"2016","journal-title":"Eye"},{"key":"B38-20240828","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/0042-6989(95)00246-4","article-title":"Abnormalities of the retinal cone system in retinitis pigmentosa","volume":"36","author":"Hood","year":"1996","journal-title":"Vision Res"},{"key":"B39-20240828","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/0042-6989(95)00327-4","article-title":"An alternative phototransduction model for human rod and cone ERG a-waves:Normal parameters and variation with age","volume":"36","author":"Cideciyan","year":"1996","journal-title":"Vision Res"},{"key":"B41-20240828","first-page":"175","article-title":"Histopathology of the human retina in retinitis pigmentosa","volume":"17","author":"Milam","year":"1998","journal-title":"Prog Retin Eye Res"},{"key":"B42-20240828","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0039-6257(00)00140-5","article-title":"The role of oxidative stress in the pathogenesis of age-related macular degeneration","volume":"45","author":"Beatty","year":"2000","journal-title":"Surv Ophthalmol"},{"key":"B43-20240828","first-page":"1301","article-title":"Oxidative damage in age-related macular degeneration","volume":"22","author":"Shen","year":"2007","journal-title":"Histol Histopathol"},{"key":"B44-20240828","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/archopht.121.8.1099","article-title":"Maculas affected by age-related macular degeneration contains increased chelate iron in the retinal pigment epithelium and Bruch's membrane","volume":"121","author":"Hahn","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"B45-20240828","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.ophtha.2004.12.029","article-title":"Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload","volume":"112","author":"Dunaief","year":"2005","journal-title":"Ophthalmology"},{"key":"B46-20240828","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/pr.57.4.2","article-title":"The evolution of iron chelators for the treatment of iron overload disease and cancer","volume":"57","author":"Kalinowski","year":"2005","journal-title":"Pharmacol Rev"},{"key":"B47-20240828","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1699-0463.1999.tb01499.x","article-title":"Lactoferrin:A multifunctional glycoprotein","volume":"107","author":"Vorland","year":"1999","journal-title":"APMIS"},{"issue":"(12)","key":"B48-20240828","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1093\/jn\/nxaa226","article-title":"Iron absorption is greater from Apo-Lactoferrin and is similar between Holo-Lactoferrin and ferrous sulfate: stable iron isotope studies in Kenyan infants","volume":"150","author":"Mikulic","year":"2020","journal-title":"The Journal of Nutrition"},{"key":"B49-20240828","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.2217\/nnm-2020-0090","article-title":"Targeting cancer with lactoferrin nanoparticles:Recent advances","volume":"15","author":"Kondapi","year":"2020","journal-title":"Nanomedicine (Lond)"},{"key":"B50-20240828","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems:Recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J Nanobiotechnol"},{"issue":"s3","key":"B51-20240828","first-page":"151","article-title":"The blood-brain barrier in vitro:co-culture of brain capillary endothelial cells and astrocytes","volume":"7","author":"Dehouck","year":"1990","journal-title":"Circulation et metabolisme du cerveau."},{"key":"B52-20240828","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1139\/o06-048","article-title":"Human lactoferrin controls the level of retinoblastoma protein and its activity","volume":"84","author":"Son","year":"2006","journal-title":"Biochem Cell Biol"},{"key":"B53-20240828","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/0883073815587943","article-title":"Retinoblastoma","volume":"31","author":"Ortiz","year":"2016","journal-title":"J Child Neurol"},{"key":"B54-20240828","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/00006982-200412000-00002","article-title":"Update on retinoblastoma","volume":"24","author":"Abramson","year":"2004","journal-title":"Retina"},{"key":"B55-20240828","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/APO.0000000000000172","article-title":"Unilateral?retinoblastoma managed with intravenous chemotherapy versus intra-arterial chemotherapy","volume":"5","author":"Shields","year":"2016","journal-title":"Outcomes based on the international classification of retinoblastoma. Asia Pac J Ophthalmol (Phila)"},{"key":"B56-20240828","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.4103\/ijo.IJO_721_20","article-title":"Modern treatment of retinoblastoma:A 2020 review","volume":"68","author":"Ancona-Lezama","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"B57-20240828","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1200\/JCO.1996.14.5.1532","article-title":"Results of a stage-based protocol for the treatment of retinoblastoma","volume":"14","author":"Schvartzman","year":"1996","journal-title":"J Clin Oncol"},{"key":"B58-20240828","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/pbc.22503","article-title":"Results of a prospective study for the treatment of unilateral retinoblastoma","volume":"55","author":"Chantada","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"B59-20240828","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1073\/pnas.83.19.7391","article-title":"Molecular detection of deletions involving band q14 of chromosome 13 in retinoblastomas","volume":"83","author":"Dryja","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B60-20240828","first-page":"164","article-title":"The evaluation and current concept of retinoblastoma therapy","volume":"67","author":"Reese","year":"1963","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"B61-20240828","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4172\/1948-5956.1000107","article-title":"Nano-lactoferrin in diagnostic, imaging, and targeted delivery for cancer and infectious diseases","volume":"4","author":"Kanwar","year":"2012","journal-title":"J Cancer Sci Ther"},{"key":"B62-20240828","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.exer.2015.07.011","article-title":"Upregulation of sodium iodide symporter (NIS) protein expression by an innate immunity component:Promising potential for targeting radiosensitive retinoblastoma [published correction appears in Exp Eye 2020 Sep;198:108145]","volume":"139","author":"Samuel","year":"2015","journal-title":"Exp Eye Res"},{"key":"B63-20240828","doi-asserted-by":"crossref","first-page":"e000339","DOI":"10.1136\/jitc-2019-000339","article-title":"Lactoferrin-containing immunocomplex mediates antitumor effects by resetting tumor-associated macrophages to M1 phenotype","volume":"8","author":"Dong","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B64-20240828","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/(SICI)1097-4644(19990901)74:3<486::AID-JCB16>3.0.CO;2-6","article-title":"Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells","volume":"74","author":"Damiens","year":"1999","journal-title":"J Cell Biochem"},{"key":"B65-20240828","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/jcb.10529","article-title":"Overexpression of cyclin D1 inhibits TNF-induced growth arrest","volume":"89","author":"Moneo","year":"2003","journal-title":"J Cell Biochem"},{"key":"B66-20240828","doi-asserted-by":"crossref","first-page":"8683","DOI":"10.1158\/1078-0432.CCR-04-0988","article-title":"Lactoferrin down-regulates G1 cyclin-dependent kinases during growth arrest of head and neck cancer cells","volume":"10","author":"Xiao","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B67-20240828","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/bjc.1992.4","article-title":"Isolation of a lactoferrin cDNA clone and its expression in human breast cancer","volume":"65","author":"Campbell","year":"1992","journal-title":"Br J Cancer"},{"key":"B68-20240828","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1242\/jcs.01189","article-title":"The Rb network","volume":"117","author":"DeGregori","year":"2004","journal-title":"J. Cell Sci"},{"key":"B69-20240828","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/jop.1986.2.67","article-title":"Topical ocular drug delivery:Recent developments and future challenges","volume":"2","author":"Lee","year":"1986","journal-title":"J Ocul Pharmacol"},{"key":"B70-20240828","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/jop.2012.0200","article-title":"Novel strategies for anterior segment ocular drug delivery","volume":"29","author":"Cholkar","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"key":"B71-20240828","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1350-9462(97)00002-5","article-title":"Ophthalmic drug delivery systems--recent advances","volume":"17","author":"Bourlais","year":"1998","journal-title":"Prog Retin Eye Res"},{"key":"B72-20240828","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/APO.0000000000000156","article-title":"Nanotechnology for the prevention and treatment of cataract","volume":"4","author":"Cetinel","year":"2015","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"B73-20240828","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12247-015-9224-7","article-title":"Modeling, optimization, and in vitro corneal permeation of chitosan-lomefloxacin HCl nanosuspension intended for ophthalmic delivery","volume":"10","author":"Abdelrahman","year":"2015","journal-title":"J Pharm Innov"},{"key":"B74-20240828","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ajo.2007.11.017","article-title":"Changes in the quality-of-life of people with keratoconus","volume":"145","author":"Kymes","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"B75-20240828","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ajo.2016.12.015","article-title":"Age-specific incidence and prevalence of keratoconus:A nationwide registration study","volume":"175","author":"Godefrooij","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"B76-20240828","first-page":"2055","article-title":"Proteomic analysis of the tear film in patients with keratoconus","volume":"16","author":"Lema","year":"2010","journal-title":"Mol Vis"},{"key":"B77-20240828","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1167\/iovs.08-1882","article-title":"Bovine lactoferrin stimulates human corneal epithelial alkali wound healing in vitro","volume":"50","author":"Pattamatta","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B78-20240828","doi-asserted-by":"crossref","first-page":"12975","DOI":"10.1038\/s41598-017-13525-7","article-title":"Higher expression of toll-like receptors 2 and 4 in blood cells of keratoconus patiens","volume":"7","author":"Sobrino","year":"2017","journal-title":"Sci Rep"},{"key":"B79-20240828","first-page":"3862018","article-title":"Biomarkers for diagnosis and prognosis of corneal ectatic disorders","author":"Gesto","journal-title":"US Patent US15\/551"},{"key":"B80-20240828","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000078612","article-title":"Uveitis:A potentially blinding disease","volume":"218","author":"Durrani","year":"2004","journal-title":"Ophthalmologica"},{"key":"B81-20240828","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ophtha.2003.06.014","article-title":"Incidence and prevalence of uveitis in Northern California:The Northern California Epidemiology of uveitis study","volume":"111","author":"Gritz","year":"2004","journal-title":"Ophthalmology"},{"key":"B82-20240828","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-0420.1997.tb00255.x","article-title":"Incidence and prevalence of different uveitis entities in Finland","volume":"75","author":"P\u00e4iv\u00f6nsalo-Hietanen","year":"1997","journal-title":"Acta Ophthalmol Scand"},{"key":"B83-20240828","doi-asserted-by":"crossref","first-page":"18975","DOI":"10.1074\/jbc.R115.650150","article-title":"Regulation of iron metabolism by hepcidin under conditions of inflammation","volume":"290","author":"Schmidt","year":"2015","journal-title":"J Biol Chem"},{"key":"B84-20240828","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1182\/blood-2013-08-521419","article-title":"A mouse model of anemia of inflammation:Complex pathogenesis with partial dependence on hepcidin","volume":"123","author":"Kim","year":"2015","journal-title":"Blood"},{"key":"B85-20240828","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1182\/blood-2010-05-286260","article-title":"Detection, evaluation, and management of iron-restricted erythropoiesis","volume":"116","author":"Goodnough","year":"2010","journal-title":"Blood"},{"key":"B86-20240828","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood-2013-08-521625","article-title":"Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus","volume":"123","author":"Gardenghi","year":"2014","journal-title":"Blood"},{"key":"B87-20240828","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3109\/02713683.2015.1075220","article-title":"Lactoferrin expression in human and murine ocular tissue","volume":"41","author":"Rageh","year":"2016","journal-title":"Curr Eye Res"},{"key":"B88-20240828","first-page":"1","article-title":"EFSA Panel on Dietetic Products, Nutrition, and Allergies (NDA). Scientific Opinion on bovine lactoferrin","volume":"10","year":"2012","journal-title":"EFSA J"},{"key":"B89-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mehy.2017.03.029","article-title":"Iron chelation for the treatment of uveitis","volume":"103","author":"Chen","year":"2017","journal-title":"Med Hypotheses"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_303_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:02:58Z","timestamp":1787756578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_303_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":85,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_303_22","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,30]]},"assertion":[{"value":"2021-01-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}